Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F6ZH
|
|||
| Former ID |
DNC008430
|
|||
| Drug Name |
3-(2-naphthyl)phenol
|
|||
| Synonyms |
3-(2-naphthyl)phenol; 2-(3-Hydroxyphenyl)naphthalene; 3-(NAPHTHALEN-2-YL)PHENOL; 33104-32-4; CHEMBL258687; 3-Naphthalene-2-ylphenol; 3-naphthalen-2-yl-phenol; SCHEMBL3015094; DTXSID90487649; FQDQJXSIUCYJDC-UHFFFAOYSA-N; BDBM50373033
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12O
|
|||
| Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)C3=CC(=CC=C3)O
|
|||
| InChI |
1S/C16H12O/c17-16-7-3-6-14(11-16)15-9-8-12-4-1-2-5-13(12)10-15/h1-11,17H
|
|||
| InChIKey |
FQDQJXSIUCYJDC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 33104-32-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) | Target Info | Inhibitor | [1] |
| BioCyc | Superpathway of steroid hormone biosynthesis | |||
| Estradiol biosynthesis I | ||||
| KEGG Pathway | Steroid hormone biosynthesis | |||
| Metabolic pathways | ||||
| Ovarian steroidogenesis | ||||
| NetPath Pathway | FSH Signaling Pathway | |||
| Panther Pathway | Androgen/estrogene/progesterone biosynthesis | |||
| Pathwhiz Pathway | Androgen and Estrogen Metabolism | |||
| Reactome | The canonical retinoid cycle in rods (twilight vision) | |||
| WikiPathways | Steroid Biosynthesis | |||
| Metabolism of steroid hormones and vitamin D | ||||
| Prostate Cancer | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors... J Med Chem. 2008 Apr 10;51(7):2158-69. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.